(2,2-Dimethyl-2,3-dihydro-1-benzofuran-5-yl)methanamine | 132570-56-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 香豆素
• 英文名称: (2,2-Dimethyl-2,3-dihydro-1-benzofuran-5-yl)methanamine
• 英文别名: (2,2-dimethyl-3H-1-benzofuran-5-yl)methanamine
• CAS: 132570-56-0
• 化学式: C₁₁H₁₅NO
• mdl: MFCD09971144
• 分子量: 177.24
• InChiKey: TVVYGQVELAATAQ-UHFFFAOYSA-N

物化性质

• 沸点：
  276℃
• 密度：
  1.055
• 闪点：
  121℃

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.454
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• [EN] BENZYL AMINE-CONTAINING HETEROCYCLIC COMPOUNDS AND COMPOSITIONS USEFUL AGAINST MYCOBACTERIAL INFECTION<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES CONTENANT DE LA BENZYLAMINE ET COMPOSITIONS UTILES CONTRE UNE INFECTION MYCOBACTÉRIENNE
  申请人：MILLER MARVIN J

  公开号：WO2017049321A1

  公开（公告）日：2017-03-23

  Described herein are compounds and compositions, and methods of making and their use as effective agents against mycobacterial infections.

  本文描述了化合物和组合物，以及制备方法及其用作抗结核菌感染的有效药剂。
• Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection
  申请人：UNIVERSITY OF NOTRE DAME DU LAC

  公开号：US10919888B2

  公开（公告）日：2021-02-16

  Described herein are compounds and compositions, and methods of making and their use as effective agents against mycobacterial infections.

  本文描述的是化合物和组合物，以及作为抗霉菌感染的有效制剂的制造和使用方法。
• Compounds, salts thereof and methods for treatment of diseases
  申请人：ACADIA PHARMACEUTICALS INC.

  公开号：US11345693B2

  公开（公告）日：2022-05-31

  The present disclosure relates to compounds according to Formula (I), useful for treating diseases.

  本公开涉及可用于治疗疾病的式 (I) 化合物。
• Heterobicyclic metalloprotease inhibitors
  申请人：Steeneck Christoph

  公开号：US20070155738A1

  公开（公告）日：2007-07-05

  The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-13 inhibiting and MMP-3 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP-13 and MMP-3 inhibitors.
• Heterotricyclic metalloprotease inhibitors
  申请人：Gege Christian

  公开号：US20080207607A1

  公开（公告）日：2008-08-28

  The present invention relates generally to azatriocyclic containing pharmaceutical agents, and in particular, to azatricyclic metalloprotease inhibiting compounds. More particularly, the present invention provides a new class of azatricyclic MMP-3, MMP-8 and/or MMP-13 inhibiting compounds, that exhibit an increased potency and selectivity in relation to currently known MMP-13, MMP-8 and MMP-3 inhibitors.